MSCI CPO earns 6,042 performance stock options

MSCI Inc. Chief Product Officer Alvise J. Munari received 6,042 performance stock options to purchase common stock.

Rhea-AI Filing Summary

MSCI Inc. Chief Product Officer Alvise J. Munari received 6,042 performance stock options to purchase common stock. These options were earned after the Compensation, Talent and Culture Committee certified on January 26, 2026 that the performance condition for the 2023–2025 measurement period was achieved.

The performance stock options were originally granted on February 2, 2023 and are scheduled to vest on February 2, 2026, the third anniversary of the grant date, subject to Mr. Munari’s continued service through that date.

Insider Trade Summary

Grant/Award: 6,042 shares

Grant/Award 1 txn

Insider Munari Alvise J.

Role Chief Product Officer

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock	6,042	$0.00	$0.00

Holdings After Transaction: Option to purchase common stock — 6,042 contracts (Direct)

Footnotes (1)

1. F1. Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 6,042 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MSCI (MSCI) report for Alvise J. Munari?

MSCI reported that Chief Product Officer Alvise J. Munari received 6,042 performance stock options. These derivative awards were earned after the compensation committee certified achievement of the applicable performance condition for the 2023–2025 period and follow a grant originally made on February 2, 2023.

How many MSCI (MSCI) performance stock options did Alvise J. Munari earn?

Alvise J. Munari earned 6,042 performance stock options linked to MSCI common stock. The certification on January 26, 2026 confirmed the performance condition was met with respect to 6,042 underlying shares, establishing the number of options that will be eligible to vest in 2026.

When do Alvise J. Munari’s MSCI (MSCI) performance stock options vest?

The performance stock options are scheduled to vest on February 2, 2026. This vesting date is the third anniversary of the original February 2, 2023 grant and is contingent on Mr. Munari’s continuous service through that date and satisfaction of the performance condition.

What performance period applies to the MSCI (MSCI) performance stock options for Alvise J. Munari?

The options are tied to a performance period from January 1, 2023 through December 31, 2025. The Compensation, Talent and Culture Committee certified on January 26, 2026 that the performance condition for this period was achieved, earning 6,042 underlying shares for vesting.

What role did MSCI’s committee play in Alvise J. Munari’s stock options?

MSCI’s Compensation, Talent and Culture Committee certified on January 26, 2026 that the performance condition for the performance stock options was achieved. This certification determined that 6,042 options were earned and would remain subject to time-based vesting on February 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/28/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munari Alvise J.

(Last) (First) (Middle)

MSCI INC.

7 WORLD TRADE CENTER, 250 GREENWICH ST.

(Street)

NEW YORK NY 10007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MSCI Inc. [ MSCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$554.52	01/26/2026		A		6,042(1)		02/02/2026	02/02/2033	Common Stock	6,042	$0	6,042	D

Explanation of Responses:

1. Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 6,042 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.

Remarks:

	/s/ Cecilia Aza, attorney-in-fact	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.